YEAR
- 2017.04.10 MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1. Shichita T, Ito M, Morita R, Komai K, Noguchi Y, Ooboshi H, Koshida R, Takahashi S, Kodama T, Yoshimura A.Nat. Med. 2017 Jun;23(6):723-732. doi: 10.1038/nm.4312
- 2017.04.10 Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2. Nagata N, Iwanari H, Kumagai H, Kusano-Arai O, Ikeda Y, Aritake K, Hamakubo T, Urade Y.PLoS ONE. 2017;12(4):e0175452. doi: 10.1371/journal.pone.0175452
- 2017.03.24 Visualization of ligand-induced Gi-protein activation in chemotaxing cells. Masuda K, Kitakami JI, Kozasa T, Kodama T, Ihara S, Hamakubo T.FASEB J. 2017 Mar;31(3):910-919. doi: 10.1096/fj.201601102R
- 2017.03.16 Crystal Structure of the Minimal Cas9 from Campylobacter jejuni Reveals the Molecular Diversity in the CRISPR-Cas9 Systems Yamada M, Watanabe Y, Gootenberg JS, Hirano H, Ran FA, Nakane T, Ishitani R, Zhang F, Nishimasu H, Nureki O.Mol. Cell. 2017 Mar 16;65(6):1109-1121.e3. doi: 10.1016/j.molcel.2017.02.007
- 2017.03.07 Genetic and epigenetic stability of oligodendrogliomas at recurrence. Aihara K, Mukasa A, Nagae G, Nomura M, Yamamoto S, Ueda H, Tatsuno K, Shibahara J, Takahashi M, Momose T, Tanaka S, Takayanagi S, Yanagisawa S, Nejo T, Takahashi S, Omata M, Otani R, Saito K, Narita Y, Nagane M, Nishikawa R, Ueki K, Aburatani H, Saito N.Acta Neuropathol Commun. 2017 03 07;5(1):18. doi: 10.1186/s40478-017-0422-z
- 2017.03.06 Epiregulin-blocking antibody inhibits epiregulin-dependent EGFR signaling. Iijima M, Anai M, Kodama T, Shibasaki Y.Biochem. Biophys. Res. Commun. 2017 07 15;489(1):83-88. doi: 10.1016/j.bbrc.2017.03.006
- 2017.02.28 Extracellular Acidic pH Activates the Sterol Regulatory Element-Binding Protein 2 to Promote Tumor Progression. Kondo A, Yamamoto S, Nakaki R, Shimamura T, Hamakubo T, Sakai J, Kodama T, Yoshida T, Aburatani H, Osawa T.Cell Rep. 2017 02 28;18(9):2228-2242. doi: 10.1016/j.celrep.2017.02.006
- 2017.01.27 Molecular Pathology and Novel Clinical Therapy for Uterine Leiomyosarcoma. Hayashi T, Kawano M, Ichimura T, Ida K, Ando H, Zharhary D, Kanai Y, Aburatani H, Tonegawa S, Shiozawa T, Yaegashi N, Konishi I.Anticancer Res. 2016 10;36(10):4997-5007. doi: 10.21873/anticanres.11068
CLOSE